Sepsis due to streptococcus, group B
ICD-10 A40.3 is a billable code used to indicate a diagnosis of sepsis due to streptococcus, group b.
Sepsis due to Group B Streptococcus (GBS) is a severe systemic infection that arises from the presence of GBS bacteria in the bloodstream. GBS is a common bacterium found in the gastrointestinal and genitourinary tracts of healthy adults, but it can cause serious infections, particularly in vulnerable populations such as newborns, pregnant women, and the elderly. In newborns, GBS can lead to early-onset sepsis, which occurs within the first week of life, or late-onset sepsis, which occurs after the first week. Symptoms of sepsis include fever, chills, rapid heart rate, confusion, and difficulty breathing. The condition can progress rapidly, leading to septic shock and multi-organ failure, necessitating immediate medical intervention. Treatment typically involves the administration of broad-spectrum antibiotics, followed by targeted therapy based on culture results. ICU care may be required for severe cases, emphasizing the importance of antimicrobial stewardship to prevent resistance and ensure effective treatment.
Detailed clinical notes on the patient's infection history, laboratory results, and treatment response.
Patients presenting with fever and signs of systemic infection, particularly in high-risk populations.
Documentation must clearly indicate the source of infection and any relevant comorbidities.
Thorough documentation of maternal GBS status, neonatal symptoms, and treatment protocols.
Newborns presenting with signs of sepsis, especially in the first week of life.
Special attention to the timing of symptom onset and maternal history is crucial.
Used to confirm the presence of GBS in a patient suspected of sepsis.
Document the source of the culture and clinical indications for testing.
Infectious disease specialists may require additional details on the patient's history.
Accurate coding of A40.3 is crucial for appropriate treatment, resource allocation, and tracking of infection trends. It also impacts reimbursement and quality metrics in healthcare.
